First human tests begin for new Alzheimer's drug candidate in china
NCT ID NCT07346495
Summary
This is an early-stage study to check the safety and how the body processes a single dose of an experimental drug called remternetug. It will involve 24 healthy Chinese volunteers who will receive an injection under the skin. The main goal is to see how well the drug is tolerated and to measure its levels in the blood over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Xuhui Central Hospital
RECRUITINGXuhui District, 20031, China
Contact
-
Xuanwu Hospital Capital Medical University
RECRUITINGBeijing, 100053, China
Contact
Conditions
Explore the condition pages connected to this study.